Influence of experimental hypercholesterolemia on the monoamine oxidase activity in rabbit arteries

Pharmacological Research

Volumn 33, Issue 4-5, 1996, Pages 245-249

  Caramona, M M ^a   Cotrim, M D ^b   Figueiredo, I V ^b   Tavares, P ^b   Ribeiro, C A Fontes ^b   Beja, M L ^b   Wulfroth, P ^b   Teixeira, F ^b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b NONE

Author keywords

Atherogenesis; Monoamine oxidase; Noradrenaline; Rabbit arteries

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CHOLESTEROL; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMORAL ARTERY; HYPERCHOLESTEROLEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0030130460     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1996.0034     Document Type: Article

References (27)

1. 1. Wince LC, Rutledge CO. Developmental changes in the accumulation of norepinephrine and the chronotropic effects of catecholamines in isolated rata atria as influenced by dietary lipid. J Pharmacol Exp Therap 1982; 220: 340-6.
2. 2. Panek RL, Dixon WR, Rutledge CO. Modification of sympathetic neuronal function in the rat tail artery by dietary lipid treatment. J Pharmacol Exp Therap 1985; 233: 578-83.
3. 3. Semafuko WEB, Rutledge CO, Dixon WR. Effect of dietary lipids on myocardial norepinephrine content and field stimulation-mediated release of norepinephrine from perfused neonatal and adult rat hearts. J Cardiovasc Pharmacol 1987; 10: 16-23.
4. 4. Teixeira F, Matos Beja ML, Serra e Silva P, Cabrita S, França MBV, Almeida L, Morgadinho MT. Experimental atherogenesis and vascular noradrenaline content in NZW rabbits and activity of a new nicotonic acid derivative (L44-0). J Lipid Mediators 1991; 3: 167-75.
5. 5. Paton DM. Cation and metabolic requirements for retention of metaraminol by rat uterine horns. Br J Pharmacol Chemoth 1968; 33: 277-86.
6. 6. De La Lande IS. Adrenergic mechanisms in the rabbit ear artery. Blood Vessels 1975; 12: 137-60.
7. 7. Head RJ, Stitzel RE, De La Lande IS, Johnson SM. The effect of chronic denervation on the activities of monoamine oxidase and catechol-O-methyltransferase and on the contents of noradrenaline and adenosine triphosphate in the rabbit ear artery. Blood Vessels 1977; 14: 229-39.
8. 8. Branco D, Caramona MM, Araújo D, Osswald W. The role of monoamine oxidase in the metabolism of exogenous noradrenaline by the human saphenous vein. Fund Clin Pharmacol 1992; 6: 145-52.
9. 9. Fowler CJ, Calligham BA, Mantle TJ, Tipton KF. Monoamine oxidase A and B - A useful concept. Biochem Pharmacol 1978; 27: 97-111.
10. 10. Boerhinger Ingelheim Diagnostika 1983: Instruction sheets for biochemical assays.
11. 11. Ericksson BM, Persson BA. Determination of cat-echolamines in the rat tissue and plasma samples by liquid chromatography with electrochemical detection. J Chromatogr 1982; 228: 143-54.
12. 12. Hjemdall P. Catecholamine measurements by high performance liquid chromatography. Am J Physiol 1984; 247: 13-20.
13. 13. Shoup RE, Mayer GS. Determination of plasma norepinephrine by liquid chromatography/electrochemistry. In: Kabra PM, Marton LJ, eds. Clinical liquid chromatography. CRC Press, Boca Raton, 1984: Vol. II, 47-51.
14. 14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
15. 15. Jarrot B. Occurrence and properties of monoamine oxidase in adrenergic neurons. J Neurochem 1971; 18: 7-16.
16. 16. Goridis C, Neff NH. Monoamine oxidase in sympathetic nerves; a transmitter specific enzyme type. Br J Pharmacol 1971; 43: 814-8.
17. 17. Neff NH, Yang HYT. Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs. Life Sci 1974; 14: 2061-74.
18. 18. Branco D, Caramona MM, Martel F, Ferreira de Almeida JA, Osswald W. Predominance of oxidative deamination in the metabolism of endogenous noradrenaline by the normal and chemically denervated human uterine artery. Naunyn-Schmiedeberg's Arch Pharmacol 1992; 323: 128-40.
19. 19. Caramona MM. Monoamine oxidase of types A and B in the saphenous vein and mesenteric artery of the dog. Naunyn-Schmiedeberg's Arch Pharmacol 1982; 319: 121-4.
20. 20. Wilkinson GN. Statistical estimations in enzyme kinetics. Biochem J 1961; 80: 324-32.
21. 21. Caramona MM. Localization of monoamine oxidase type A and B in blood vessels with different innervation patterns. Naunyn-Schmiedeberg's Arch Pharmacol 1983; 324: 185-9.
22. 22. Precious E, Gunn CE, Lyles GA. Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta. Biochem Pharmacol 1988; 37: 707-13.
23. 23. Buffoni F. Properties, distribution and physiological role of semicarbazide-sensitive amine oxidases. Curr Topics Pharmacol 1993; 2: 33-50.
24. 24. Borochov VH, Abbott RE, Schachter D, Shinitzky M. Modulation of erythrocyte membrane protein by membrane cholesterol and lipid fluidity. Biochemistry 1979; 18: 251-5.
25. 25. Lewinsohn R. Mammalian monoamine-oxidizing enzymes, with special reference to benzylamine oxidase in human tissues. Brazilian J Med Biol Res 1984; 17: 223-56.
26. 26. Osswald W. Oxidative deamination of noradrenaline in human blood vessels. J Neural Transm 1990; Suppl 32: 395-404.
27. 27. Farias RN, Bloj B, Morero RD, Siñeriz F, Trucco RE. Regulation of allosteric membrane-bound enzymes through changes in membrane lipid composition. Biochim Biophys Acta 1975; 415: 231-51.